Osaic Holdings’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-40
| Closed | -$80 | – | 7718 |
|
|
2024
Q3 | $80 | Hold |
40
| – | – | ﹤0.01% | 7260 |
|
|
2024
Q2 | $66 | Hold |
40
| – | – | ﹤0.01% | 7287 |
|
|
2024
Q1 | $241 | Hold |
40
| – | – | ﹤0.01% | 6946 |
|
|
2023
Q4 | $280 | Hold |
40
| – | – | ﹤0.01% | 6984 |
|
|
2023
Q3 | $350 | Hold |
40
| – | – | ﹤0.01% | 7052 |
|
|
2023
Q2 | $470 | Hold |
40
| – | – | ﹤0.01% | 7067 |
|
|
2023
Q1 | $685 | Hold |
40
| – | – | ﹤0.01% | 7071 |
|
|
2022
Q4 | $1K | Hold |
40
| – | – | ﹤0.01% | 7007 |
|
|
2022
Q3 | $4K | Buy |
+40
| New | +$5.41K | ﹤0.01% | 6538 |
|
|
2021
Q4 | – | Sell |
-40
| Closed | -$8K | – | 7627 |
|
|
2021
Q3 | $8K | Sell |
40
-29
| -42% | -$6.16K | ﹤0.01% | 6348 |
|
|
2021
Q2 | $17K | Sell |
69
-20
| -22% | -$5.48K | ﹤0.01% | 5772 |
|
|
2021
Q1 | $31K | Buy |
89
+40
| +82% | +$16.3K | ﹤0.01% | 5217 |
|
|
2020
Q4 | $17K | Sell |
49
-32
| -40% | -$12.3K | ﹤0.01% | 5270 |
|
|
2020
Q3 | $37K | Buy |
+81
| New | +$22.9K | ﹤0.01% | 4531 |
|
Other funds holding TFFP
Osaic Holdings's TFFP Position: Q4 2024 in Review
Osaic Holdings sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2024, closing a stake of 40 shares — an estimated $80 sold.
Osaic Holdings first reported a position in TFFP in Q3 2020 and held it in 14 quarters. The position peaked at $37K in Q3 2020. 4 funds tracked by Wall St. Rank hold TFFP as of Q4 2024.
- Osaic Holdings reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Osaic Holdings sold 40 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $80.
- Osaic Holdings first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 14 quarters.
- Osaic Holdings's TFF Pharmaceuticals, Inc. Common Stock position peaked at $37K in Q3 2020.
- 4 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2024.
Based on Osaic Holdings's 13F filing for Q4 2024, filed 7 Feb 2025.